Volume 21, Issue 2 163293 pp. 107-111
Open Access

Airway Pressure and Transpulmonary Pressure During High-Frequency Oscillation for Acute Respiratory Distress Syndrome

William R Henderson

Corresponding Author

William R Henderson

Division of Critical Care Medicine Faculty of Medicine University of British Columbia Vancouver British Columbia, Canada , ubc.ca

School of Kinesiology University of British Columbia Vancouver British Columbia, Canada , ubc.ca

Search for more papers by this author
Paolo B Dominelli

Paolo B Dominelli

School of Kinesiology University of British Columbia Vancouver British Columbia, Canada , ubc.ca

Search for more papers by this author
Donald EG Griesdale

Donald EG Griesdale

Division of Critical Care Medicine Faculty of Medicine University of British Columbia Vancouver British Columbia, Canada , ubc.ca

Search for more papers by this author
Daniel Talmor

Daniel Talmor

Department of Anesthesia Critical Care and Pain Medicine Beth Israel Deaconess Medical Center and Harvard Medical School Boston Massachusetts, USA , harvard.edu

Search for more papers by this author
A William Sheel

A William Sheel

School of Kinesiology University of British Columbia Vancouver British Columbia, Canada , ubc.ca

Search for more papers by this author
First published: 01 January 2014
Citations: 2

Abstract

BACKGROUND: High-frequency oscillation (HFO) is used for the treatment of refractory hypoxic respiratory failure.

OBJECTIVE: To demonstrate that the mean transpulmonary pressure (PL) cannot be inferred from mean airway pressure (mPaw).

METHODS: In seven patients already undergoing HFO for refractory acute respiratory distress syndrome, esophageal pressure (Pes) was measured using an esophageal balloon catheter. Pleural pressure (Ppl) and PL were calculated from Pes.

MAIN RESULTS: In the seven patients (mean [± SD] age 59±9 years) treated with HFO at 5±1 Hz and amplitude 75±10 cmH2O, the mPaw was 27±6 cmH2O, Ppl was 9±6 cmH2O and PL was 18±11 cmH2O. Successful catheter placement and measurement of Pes occurred in 100% of subjects. There was no correlation between PL and mPaw. The majority of subjects required hemodynamic support during the use of HFO; the frequency and degree of support during the study period was no different than that before the study.

CONCLUSION: The present report is the first to describe measuring Pes and calculating Ppl during HFO for acute respiratory distress syndrome. While both current guidelines and recent trials have titrated treatment based on mPaw and oxygenation, there is wide variability in PL during HFO and PL cannot be predicted from mPaw.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.